HRT Financial’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Buy |
+200,996
| New | +$14.8M | 0.06% | 166 |
|
|
2025
Q1 | – | Sell |
-5,385
| Closed | -$271K | – | 2395 |
|
|
2024
Q4 | $271K | Buy |
+5,385
| New | +$271K | ﹤0.01% | 1572 |
|
|
2024
Q2 | – | Sell |
-20,890
| Closed | -$526K | – | 2162 |
|
|
2024
Q1 | $526K | Sell |
20,890
-38,944
| -65% | -$981K | ﹤0.01% | 1170 |
|
|
2023
Q4 | $1.94M | Buy |
59,834
+27,777
| +87% | +$902K | 0.01% | 621 |
|
|
2023
Q3 | $873K | Sell |
32,057
-76,185
| -70% | -$2.07M | 0.01% | 974 |
|
|
2023
Q2 | $2.41M | Buy |
108,242
+97,741
| +931% | +$2.17M | 0.02% | 507 |
|
|
2023
Q1 | $227K | Sell |
10,501
-118,509
| -92% | -$2.56M | ﹤0.01% | 1703 |
|
|
2022
Q4 | $2.62M | Buy |
129,010
+119,319
| +1,231% | +$2.42M | 0.04% | 452 |
|
|
2022
Q3 | $248K | Sell |
9,691
-50,883
| -84% | -$1.3M | ﹤0.01% | 1962 |
|
|
2022
Q2 | $1.44M | Sell |
60,574
-42,934
| -41% | -$1.02M | 0.02% | 716 |
|
|
2022
Q1 | $2.33M | Sell |
103,508
-42,595
| -29% | -$959K | 0.02% | 521 |
|
|
2021
Q4 | $2.89M | Buy |
146,103
+90,461
| +163% | +$1.79M | 0.02% | 428 |
|
|
2021
Q3 | $1.1M | Buy |
55,642
+28,268
| +103% | +$556K | 0.01% | 1046 |
|
|
2021
Q2 | $602K | Buy |
27,374
+17,251
| +170% | +$379K | 0.01% | 1528 |
|
|
2021
Q1 | $240K | Buy |
+10,123
| New | +$240K | ﹤0.01% | 1997 |
|
|
2019
Q4 | – | Sell |
-21,650
| Closed | -$306K | – | 1164 |
|
|
2019
Q3 | $306K | Buy |
+21,650
| New | +$306K | 0.01% | 829 |
|